Generali Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.4M Sell
15,711
-2,561
-14% -$673K 0.08% 214
2026
Q1
$4.88M Sell
18,272
-1,634
-8% -$442K 0.1% 188
2025
Q4
$4.99M Buy
19,906
+1,311
+7% +$348K 0.1% 186
2025
Q3
$5.34M Buy
18,595
+1,154
+7% +$309K 0.11% 168
2025
Q2
$4.58M Sell
17,441
-1,390
-7% -$338K 0.1% 193
2025
Q1
$4.38M Sell
18,831
-6,665
-26% -$1.62M 0.11% 188
2024
Q4
$5.85M Buy
+25,496
New +$5.85M 0.15% 149

Other funds holding LH

Generali Asset Management's LH Position: Q2 2026 in Review

Generali Asset Management reduced its Labcorp (LH) stake by 14% in Q2 2026, selling an estimated $673K and leaving 15,711 shares worth $4.4M. The position accounts for 0.08% of the portfolio, ranked #214.

Generali Asset Management first reported a position in LH in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.85M in Q4 2024. 1,057 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Generali Asset Management held 15,711 shares of Labcorp worth $4.4M as of Q2 2026.
  • Generali Asset Management sold 2,561 Labcorp shares in Q2 2026, an estimated $673K.
  • Labcorp made up 0.08% of Generali Asset Management's portfolio in Q2 2026, its #214 holding.
  • Generali Asset Management first reported a position in Labcorp in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Labcorp position peaked at $5.85M in Q4 2024.
  • 1,057 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.